Accounts Payable, Current of Vitro Biopharma, Inc. from 31 Oct 2012 to 31 Jan 2025

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Vitro Biopharma, Inc. quarterly Accounts Payable, Current in USD history and change rate from 31 Oct 2012 to 31 Jan 2025.
  • Vitro Biopharma, Inc. Accounts Payable, Current for the quarter ending 31 Jan 2025 was $2,442,630, a 11% increase year-over-year.
Source SEC data
View on sec.gov
Accounts Payable, Current, Quarterly (USD)
Accounts Payable, Current, YoY Quarterly Change (%)

Vitro Biopharma, Inc. Quarterly Accounts Payable, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $2,442,630 +$235,580 +11% 31 Jan 2025 10-Q 20 Mar 2025 2025 Q1
Q3 2024 $2,163,920 -$124,777 -5.5% 31 Oct 2024 10-Q 20 Mar 2025 2025 Q1
Q2 2024 $2,318,618 31 Jul 2024 10-Q 16 Sep 2024 2024 Q3
Q1 2024 $2,179,823 +$1,262,564 +138% 30 Apr 2024 10-Q 31 May 2024 2024 Q2
Q4 2023 $2,207,050 +$1,345,242 +156% 31 Jan 2024 10-Q 14 Mar 2024 2024 Q1
Q3 2023 $2,288,697 +$1,684,091 +279% 31 Oct 2023 10-K 28 Jan 2025 2024 FY
Q1 2023 $917,259 30 Apr 2023 10-Q 13 Jun 2023 2023 Q2
Q4 2022 $861,808 31 Jan 2023 10-Q 14 Mar 2023 2023 Q1
Q3 2022 $604,606 31 Oct 2022 10-Q 13 Jun 2023 2023 Q2
Q3 2015 $63,808 +$15,832 +33% 31 Oct 2015 10-K 22 Sep 2016 2015 FY
Q2 2015 $61,935 +$20,180 +48% 31 Jul 2015 10-Q 30 Mar 2016 2015 Q3
Q1 2015 $64,141 +$13,854 +28% 30 Apr 2015 10-Q 22 Jan 2016 2015 Q2
Q4 2014 $36,246 +$13,693 +61% 31 Jan 2015 10-Q 24 Mar 2015 2015 Q1
Q3 2014 $47,976 +$19,738 +70% 31 Oct 2014 10-K 22 Sep 2016 2015 FY
Q2 2014 $41,755 +$5,600 +15% 31 Jul 2014 10-Q 22 Sep 2014 2014 Q3
Q1 2014 $50,287 -$2,299 -4.4% 30 Apr 2014 10-Q 19 Jun 2014 2014 Q2
Q4 2013 $22,553 31 Jan 2014 10-Q 17 Mar 2014 2014 Q1
Q3 2013 $28,238 -$9,786 -26% 31 Oct 2013 10-K 13 Feb 2015 2014 FY
Q2 2013 $36,155 31 Jul 2013 10-Q 23 Sep 2013 2013 Q3
Q1 2013 $52,586 30 Apr 2013 10-Q 18 Jun 2013 2013 Q2
Q3 2012 $38,024 31 Oct 2012 10-K 12 Feb 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.